| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 1 security · passive | ||||||
|
Odyssey Therapeutics, Inc.
13G
ODTX · 67613T104
|
7.6% |
5/18/2026
Event 5/11/2026
|
||||
| Lightspeed Venture Partners XV-B (Ignite), L.P. | 7.6% | |||||
| Lightspeed General Partner XV-B (Ignite), L.P. | 7.6% | |||||
| Lightspeed Ultimate General Partner XV-B (Ignite), L.L.C. | 7.6% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.